增强现实导航辅助肝切除术治疗肝内胆管结石的初步疗效探索
结果显示AR组手术时间更长,但术中出血量、术后即刻结石残留率及6个月结石复发率均低于非AR组,两组术后并发症无显著差异。
要点
- AR-ANS辅助肝切除术可降低肝内胆管结石患者术中出血量。
- AR-ANS组术后即刻结石残留率和6个月复发率低于非AR组。
- AR-ANS组手术时间更长,但术后并发症与非AR组无显著差异。
核心结论
- AR-ANS用于肝内胆管结石肝切除术疗效满意,在减少术中出血、即刻结石残留率和结石复发率方面有显著优势,具有临床推广价值。
主要发现
- 两组术前基线资料无显著差异(p > 0.05)。
- AR组手术时间长于非AR组(p < 0.001)。
- AR组术中出血量低于非AR组(p < 0.001)。
- AR组丙氨酸转氨酶、氨基转移酶、即刻结石残留率及结石复发率均低于非AR组(p < 0.05)。
- 两组术后并发症无显著差异。
关键数值与推荐
- AR组手术时间长于非AR组(p < 0.001),术中出血量低于非AR组(p < 0.001)。
- AR组丙氨酸转氨酶、氨基转移酶、即刻结石残留率及结石复发率均低于非AR组(p < 0.05)。
- 两组术后并发症无显著差异。
临床怎么用
- 在肝内胆管结石肝切除术中可考虑应用AR-ANS导航,以降低术中出血和结石残留、复发风险,但需权衡手术时间延长。
局限性
- 本研究为单中心回顾性研究,样本量有限,结论需进一步多中心前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The augmented reality-assisted navigation system (AR-ANS) has been initially applied to the management of hepatolithiasis. The current study examines the safety and efficacy of the AR-ANS for hepatectomy in the treatment of hepatolithiasis. It is the first study to assess the preoperative and long-term outcomes of hepatectomy guided by the AR-ANS for hepatolithiasis. STUDY DESIGN: From January 2018 to December 2021, 77 patients with hepatolithiasis who underwent hepatectomy at Zhujiang Hospital of Southern Medical University were included. The subjects were divided into the AR group (n = 31) and the non-AR group (n = 46) according to whether the surgery was guided by the AR-ANS. Clinical baseline features, operation time, intraoperative blood loss, immediate postoperative residual stone rate, postoperative stone recurrence rate at 6 months, and postoperative complications were analyzed. RESULTS: There was no significant difference between preoperative baseline data from the 2 groups (p > 0.05). The AR group had a longer surgical time than the non-AR group (p < 0.001). The intraoperative blood loss in the AR group was lower than in the non-AR group (p < 0.001). Alanine transaminase, aminotransferase, immediate residual stone rate, and stone recurrence rate in the AR group were lower than in the non-AR group (p < 0.05). There was no significant difference in postoperative complications between the 2 groups. CONCLUSIONS: The application of the AR-ANS in hepatectomy for hepatolithiasis has not only achieved satisfactory therapeutic efficacy, but has also shown significant advantages in reducing intraoperative blood loss, immediate stone residual rate, and stone recurrence rate, which has clinical promotion value.
引用
- Wu X, Zeng N, Hu H, et al. Preliminary Exploration on the Efficacy of Augmented Reality-Guided Hepatectomy for Hepatolithiasis. J Am Coll Surg. 2022. PMID: 36106869. doi:10.1097/XCS.0000000000000285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。